Molecular Partners Statistics
NASDAQ: MOLNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.81+0.03 (+0.79%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Molecular Partners by the numbers
Molecular Partners has a market capitalization of $145.9 million based on 38.31M shares outstanding. With trailing EPS of $-1.71, Molecular Partners is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.4% below its 50-day average and 9.8% below its 200-day average.
Average daily trading volume is 1.19K shares, or about $4,515 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MOLN valuation vs. peer median
| Metric | MOLN | Peer median | Difference |
|---|---|---|---|
| Market cap | $145.94M | $147.75M | -1% |
| Avg. volume | 1.19K | 881.74K | -100% |
Peer median across 8 companies: AVXL, ARMP, OTLK, ABOS, VYGR, HUMA, TARA, CHRS.
Valuation
- Market cap
- $145.94M
- EPS (TTM)
- $-1.71
- Shares outstanding
- 38.31M
Price and trading
- Previous close
- 3.78
- Open
- 3.81
- Day range
- 3.81 – 3.81
- 52-week range
- 3.53 – 5.36
- 52-week change
- +2.70%
- Beta
- —
- Volume
- 367
- Average volume
- 1.19K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 145.94M
- Forward Pe
- -23.29
- Eps
- -1.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.36
- Week52 Low
- 3.53
- Avg Volume
- 1,185.00
- Shares Outstanding
- 38.31M
- Ma50
- 4.16
- Ma200
- 4.23
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -28.92%
- Pct From52w Low
- 7.93%